ISPOR EU 2024
Are You Ready to Navigate the Complexities of Healthcare?
Did you know that over 70% of healthcare decision-makers cite a lack of real-world evidence as a barrier to effective product adoption? Or that healthcare systems are evolving rapidly, making it increasingly challenging to demonstrate the value of your innovations?
At Syneos Health, we understand the hurdles you face in Health Economics and Outcomes Research (HEOR), Real World Evidence (RWE), and Market Access. Our HEOR, Value & Access (VAL) and Real World & Late Phase Research (RWLP) teams are dedicated to transforming these challenges into opportunities.
Why Schedule a Meeting with Us?
- Proven Value: Our experts focus on delivering the evidence you need to support healthcare decision-making and enhance access to your products.
- Expert Insights: Our team of incredibly knowledgeable and experienced specialists include epidemiologists and biostatisticians—brings a wealth of expertise to help you navigate the intricacies of real-world research.
- Tailored Solutions: We design fit-for-purpose strategies that combine scientific rigor with innovative approaches, ensuring you get actionable insights that resonate with your stakeholders.
.
Meet with Us
Join us at booth #613 to explore how we can help you overcome your unique challenges. Schedule a meeting with our team to discuss your needs and discover integrated solutions that maximize your brand’s impact in the global market.
Let’s turn challenges into success together!
Featured Sessions
Monday, November 18 | 4:00pm-7:00pm
POSTER: Assessing the Suitability of Real-World Data for Indirect Treatment Comparison Using NICE's Data Suitability Assessment Tool (DataSAT)
POSTER: Use of Artificial Intelligence to Support Chart Review Studies: A Scoping Review
Tuesday, November 19 | 10:30am-1:30pm
POSTER: A Multi-Country Observational Study to Quantify Time and Satisfaction Comparing the Usage of Natalizumab Subcutaneous and Intravenous Formulations
POSTER: A Systematic Review of Health Economic Evaluation on Therapies for the Treatment of Inherited Retinal Diseases: A Quality Evaluation
POSTER: Navigating RWE Strategies in HTA Submissions for Ultra-Rare Diseases in Key European Healthcare Systems
Tuesday, November 19 | 4:00pm-7:00pm
POSTER: Comparison of Rheumatoid Arthritis Treatment Patterns Pre-, during, and Post-COVID-19 Quarantine in the United States: National Data from the Trinetx Network
Tuesday, November 19 | 5:00pm-6:00pm
HEOR WORKSHOP: Acceptance of Machine Learning Methods for Matching in ECA
Wednesday, November 20 | 9:00am-11:30pm
POSTER: Methodological Challenges in the Economic Evaluation of Cell and Gene Therapies in Oncology: Examples of UK and France
Date & Time TBD
POSTER: The Changing Landscape Of Health Technology Assessment (HTA) In The Asia-Pacific (APAC) Region: Advances, Challenges, and Future Goals
Related Content
Want to learn more? Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below:
Capabilities
Real World Research at Syneos Health
Health Economics and Outcomes Research (HEOR)
Syneos Health Time and Motion Studies
Syneos Health Pregnancy Safety Studies
Cell & Gene Market Access Solutions
Insights
Using Real World Evidence for Externally Controlled Trials in Rare Disease Drug Development
EUnetHTA Roadmap and its Implications on Biotech/ Pharma Manufacturers
Potential Impact of EU Pharma Legislation on Commercialization and Access of New Therapies
BLOG | RWE, RWD and Tokenization for Asset Development: What Biopharma Teams Need to Know
Syneos Health Podcast | Real Talk About the Inflation Reduction Act
Syneos Health Podcast | Patient Assistance: The Best Deal in Pharma
Journal Publications
A Causal Roadmap for Generating High-Quality Real-World Evidence
Aiding the Adoption of Master Protocols by Optimizing Patient Engagement
ClinicoEconomics and Outcomes Research (2021): T&M survey using online survey platform
